Business Context and Reporting Period
Company: Exagen Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 13, 2021 (Events reported through October 19, 2021)
Context: The Company entered into amendments to extend three existing lease agreements for its headquarters and adjacent office/laboratory space in Vista, California.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or liquidity metrics. It discloses future fixed financial obligations related to lease extensions:
- 1221 Lease Extension (Adjacent Office):
- Feb 1, 2026 – Jan 31, 2027: $22,470 per month
- Feb 1, 2027 – Apr 30, 2027: $23,594 per month
- 1261 Suite B/C Lease Extension (Headquarters):
- Feb 1, 2026 – Apr 30, 2027: $20,084.42 per month
- 1261 Suite A Lease Extension (Office/Lab):
- Feb 1, 2026 – Apr 30, 2027: $14,750.63 per month
Material Changes
The primary material change is the extension of the lease terms for all three properties from January 31, 2026, to April 30, 2027. This creates a direct financial obligation for the Company for the extended period.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the description of the lease extensions is not complete and refers investors to the full text of the agreements, which will be filed as exhibits to the Form 10-Q for the quarter ending September 30, 2021.
Risks/Contingencies: The filing does not explicitly list new risks or contingencies beyond the commitment to future rent payments. No unusual items were reported.
Investor Verification Checklist
- Verify the total annualized rent obligation starting February 1, 2026, by summing the monthly rates for all three leases.
- Review the full text of the lease amendments (1221, 1261 Suite B/C, and 1261 Suite A) when filed as exhibits to the Q3 2021 Form 10-Q for details on escalation clauses or termination rights.
- Confirm the Company's liquidity position in the upcoming 10-Q to ensure it can meet these future fixed obligations.